2022. Impact of Disease History on the Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s101. DOI:https://doi.org/10.25251/skin.6.supp.101.